Stocktwits on MSN
Sagimet Biosciences Stock Soars After Positive Data For Experimental Drug In Acne Study
The trial was conducted by Sagimet’s license partner for China, Ascletis Bioscience Co., in 480 patients with moderate to ...
Treatment with a 1726-nm laser resulted in sustained efficacy for moderate-to-severe acne, with more than 90% of treated patients achieving at least a 50% reduction in inflammatory lesions at 52 weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results